NorthStar Medical Radioisotopes and the Low Institute for Therapeutics (LIFT), a non-profit clinical research organization, have entered a strategic collaboration to accelerate the development, manufacturing and clinical translation of Lu177-LT17,…
NorthStar Medical Radioisotopes has entered into a multi-year strategic services agreement with QSA Global, which specializes in radioactive source manufacturing and medical radiochemical services, the company announced today. According to…
Northstar Medical Radioisotopes received notice of U.S. Food & Drug Administration (FDA) acceptance of its Type II Drug Master File (DMR) submission for the company’s no-carrier-added (n.c.a.) Actinium-225 (Ac-225), the…
NorthStar Medical Radioisotopes has entered into a strategic supply agreement with BIOEMTECH, a developer of high-resolution PET and SPECT imaging systems for preclinical and translational research, the company announced today….
NorthStar Medical Radioisotopes has been successful in routinely producing non-carrier-added Actinium-225 (Ac-225) using its electron accelerator-based technology, becoming the first in the industry to do so, the company announced recently….
NorthStar Medical Radioisotopes and the University of Wisconsin School of Medicine and Public Health have formed a multi-faceted strategic partnership, NorthStar announced today. According to a release, the multi-year partnership…
NorthStar Medical Radioisotopes and YAP Therapeutics are entering a collaboration agreement to develop and produce radiopharmaceuticals aimed at treating cancer and other chronic diseases, NorthStar announced today. According to a…
NorthStar Medical Radioisotopes and Ariceum Therapeutics have signed a supply agreement for therapeutic medical radioisotope actinium-225 (Ac-225), the company announced recently. According to a release, NorthStar will supply non-carrier added…
Cellectar Biosciences and NorthStar Medical Radioisotopes have signed a strategic supply agreement for the procurement of NorthStar’s non-carrier added (n.c.a.) Ac-225, the company announced today. “We plan to advance CLR…
NorthStar Medical Radioisotopes has expanded its strategic collaboration with Convergent Therapeutics, the company announced recently. According to a release, NorthStar will: Provide Convergent with Ac-225 for use in CONVO1-a, Use…
